167 related articles for article (PubMed ID: 38110666)
1. MET exon 14 skipping mutation drives cancer progression and recurrence via activation of SMAD2 signalling.
Liang Q; Hu Y; Yuan Q; Yu M; Wang H; Zhao B
Br J Cancer; 2024 Feb; 130(3):380-393. PubMed ID: 38110666
[TBL] [Abstract][Full Text] [Related]
2. Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination.
Wang F; Liu Y; Qiu W; Shum E; Feng M; Zhao D; Zheng D; Borczuk A; Cheng H; Halmos B
Cancer Res; 2022 Apr; 82(7):1365-1379. PubMed ID: 35078819
[TBL] [Abstract][Full Text] [Related]
3. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.
Xia YZ; Shan GF; Yang H; Zha J; Wang L; Chen JM; Zhang XS
Chem Biol Interact; 2021 Apr; 339():109424. PubMed ID: 33617803
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
[TBL] [Abstract][Full Text] [Related]
6. An N-terminally truncated Smad2 protein can partially compensate for loss of full-length Smad2.
Das D; Randall RA; Hill CS
Biochem J; 2009 Jan; 417(1):205-12. PubMed ID: 18764783
[TBL] [Abstract][Full Text] [Related]
7. Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo.
Manser C; Guillot F; Vagnoni A; Davies J; Lau KF; McLoughlin DM; De Vos KJ; Miller CC
Oncogene; 2012 May; 31(22):2773-82. PubMed ID: 21996745
[TBL] [Abstract][Full Text] [Related]
8. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
9. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
10. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
Yuki R
Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
[TBL] [Abstract][Full Text] [Related]
11. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
12. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
13. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide-binding activity of Smad2 is essential for its function in TGF-β signaling.
Buwaneka P; Ralko A; Gorai S; Pham H; Cho W
J Biol Chem; 2021 Nov; 297(5):101303. PubMed ID: 34655614
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.
Cai H; Guo F; Wen S; Jin X; Wu H; Ren D
J Exp Clin Cancer Res; 2022 Feb; 41(1):73. PubMed ID: 35193647
[TBL] [Abstract][Full Text] [Related]
16. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
Runyan CE; Schnaper HW; Poncelet AC
J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
[TBL] [Abstract][Full Text] [Related]
17. Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.
Ma PC; Tretiakova MS; Nallasura V; Jagadeeswaran R; Husain AN; Salgia R
Br J Cancer; 2007 Aug; 97(3):368-77. PubMed ID: 17667909
[TBL] [Abstract][Full Text] [Related]
18. A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.
Yang W; Gong X; Wang X; Huang C
Invest New Drugs; 2019 Oct; 37(5):865-875. PubMed ID: 30488243
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
20. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
